S&P 500   3,841.05
DOW   31,125.20
QQQ   322.68
S&P 500   3,841.05
DOW   31,125.20
QQQ   322.68
S&P 500   3,841.05
DOW   31,125.20
QQQ   322.68
S&P 500   3,841.05
DOW   31,125.20
QQQ   322.68
Log in

Alexion Pharmaceuticals Price Target, Predictions & Analyst Ratings

-0.87 (-0.55 %)
(As of 01/20/2021 11:33 AM ET)
Today's Range
Now: $157.84
50-Day Range
MA: $146.74
52-Week Range
Now: $157.84
Volume99,142 shs
Average Volume3.33 million shs
Market Capitalization$34.54 billion
P/E Ratio36.88
Dividend YieldN/A

Analyst Ratings

Alexion Pharmaceuticals (NASDAQ:ALXN) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
27 Wall Street analysts have issued ratings and price targets for Alexion Pharmaceuticals in the last 12 months. Their average twelve-month price target is $152.96, predicting that the stock has a possible downside of 3.09%. The high price target for ALXN is $200.00 and the low price target for ALXN is $73.00. There are currently 16 hold ratings, 10 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
ALXN Consensus Rating: HoldHoldBuyBuy
ALXN Consensus Rating Score: 2.442.482.682.71
ALXN Analyst Ratings: 0 Sell Rating(s)
16 Hold Rating(s)
10 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
15 Hold Rating(s)
11 Buy Rating(s)
1 Strong Buy Rating(s)
1 Sell Rating(s)
6 Hold Rating(s)
14 Buy Rating(s)
1 Strong Buy Rating(s)
1 Sell Rating(s)
6 Hold Rating(s)
16 Buy Rating(s)
1 Strong Buy Rating(s)
ALXN Consensus Price Target: $152.96$152.96$142.50$143.95
ALXN Price Target Upside: 3.09% downside30.97% upside35.48% upside41.12% upside

Alexion Pharmaceuticals (NASDAQ:ALXN) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Alexion Pharmaceuticals (NASDAQ:ALXN) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/8/2021Raymond JamesDowngradeOutperform ➝ Market PerformLow
12/16/2020TruistDowngradeBuy ➝ Hold$155.00 ➝ $175.00Medium
12/15/2020Smith Barney CitigroupDowngradeBuy ➝ Neutral$175.00Low
12/15/2020Roth CapitalBoost Price Target$50.00 ➝ $73.00Low
12/15/2020Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellReiterated RatingBuy ➝ Neutral$175.00Low
12/14/2020SVB LeerinkBoost Price TargetOutperform$159.00 ➝ $200.00High
12/14/2020Robert W. BairdDowngradeOutperform ➝ Neutral$140.00 ➝ $175.00High
12/14/2020WedbushDowngradeOutperform ➝ Neutral$175.00High
12/14/2020Royal Bank of CanadaBoost Price TargetOutperform$139.00 ➝ $175.00High
12/14/2020BMO Capital MarketsDowngradeOutperform ➝ Market Perform$152.00 ➝ $175.00High
12/14/2020Credit Suisse GroupDowngradeOutperform ➝ Neutral$147.00 ➝ $194.00High
11/19/2020Sanford C. BernsteinInitiated CoverageMarket Perform$148.00Low
10/30/2020Svb LeerinkLower Price TargetOverweight ➝ Outperform$163.00 ➝ $159.00Low
10/30/2020Morgan StanleyLower Price TargetEqual Weight$121.00 ➝ $119.00Medium
10/29/2020Piper SandlerBoost Price TargetOverweight$175.00 ➝ $179.00Medium
10/28/2020UBS GroupInitiated CoverageNeutral$133.00High
10/7/2020William BlairReiterated RatingHoldHigh
9/1/2020Stifel NicolausLower Price TargetHold$120.00 ➝ $117.00Low
7/31/2020SunTrust BanksBoost Price TargetOutperform ➝ Buy$135.00 ➝ $155.00Medium
7/30/2020OppenheimerReiterated RatingHoldMedium
5/6/2020CfraLower Price TargetStrong-Buy$165.00 ➝ $159.00Medium
5/6/2020NomuraReiterated RatingBuy$133.00Medium
4/27/2020Cantor FitzgeraldInitiated CoverageNeutral$121.00High
4/17/2020JPMorgan Chase & Co.Lower Price TargetOverweight$168.00 ➝ $163.00High
3/12/2020Wolfe ResearchInitiated CoverageOutperform$140.00High
3/5/2020Bank of AmericaDowngradeBuy ➝ Neutral$130.00 ➝ $110.00Low
2/3/2020Nomura SecuritiesLower Price TargetBuy$165.00 ➝ $133.00Low
1/30/2020CowenReiterated RatingBuy$165.00High
11/17/2019Evercore ISIReiterated RatingBuy$145.00Low
9/6/2019Piper Jaffray CompaniesSet Price TargetBuy$180.00Low
5/23/2019The Goldman Sachs GroupReiterated RatingNeutral ➝ Neutral$142.00Low
3/21/2019GuggenheimReiterated RatingNeutral ➝ Neutral$135.00High
9/28/2018BarclaysBoost Price TargetPositive ➝ Overweight$175.00Low
7/27/2018Jefferies Financial GroupReiterated RatingHold$123.00High
3/15/2018Deutsche Bank AktiengesellschaftSet Price TargetBuy$161.00High
(Data available from 1/20/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 1/20/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.